BPTH (Bio-Path Holdings) Scaled Net Operating Assets: -11.58 (As of Mar. 2026)


What is Bio-Path Holdings Scaled Net Operating Assets?

Bio-Path Holdings BPTH -20.47% Scaled Net Operating Assets is -11.58 as of Mar. 2026. The stock has 1 warning sign investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bio-Path Holdings's operating assets for the quarter that ended in Mar. 2026 was $0.67 Mil. Bio-Path Holdings's operating liabilities for the quarter that ended in Mar. 2026 was $8.65 Mil. Bio-Path Holdings's Total Assets for the quarter that ended in Sep. 2025 was $0.69 Mil. Therefore, Bio-Path Holdings's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was -11.58.

Bio-Path Holdings Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Bio-Path Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Path Holdings Scaled Net Operating Assets Chart

Bio-Path Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.12 0.15 -0.03 -0.29

Bio-Path Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.32 -0.62 -3.04 -10.09 -11.58

BPTH vs ADAPY, ZVSA, CLSDQ: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Bio-Path Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Path Holdings Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Path Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Bio-Path Holdings's Scaled Net Operating Assets falls into.


Bio-Path Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bio-Path Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(2.71-3.646)/3.22
=-0.29

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3.883 - 1.173
=2.71

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.729 - 0 - 0.083
=3.646

Bio-Path Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Sep. 2025 )
=(0.665-8.652)/0.69
=-11.58

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.677 - 0.012
=0.665

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=9.163 - 0 - 0.511
=8.652

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -11.58 mean?
Bio-Path Holdings (BPTH) has a Scaled Net Operating Assets of -11.58 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Bio-Path Holdings and its competitors.
Is Bio-Path Holdings' Scaled Net Operating Assets too high?
Bio-Path Holdings' current Scaled Net Operating Assets is -11.58.
How does Bio-Path Holdings' Scaled Net Operating Assets compare to ADAPY and ZVSA?
Bio-Path Holdings' Scaled Net Operating Assets of -11.58 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Bio-Path Holdings and its competitors. Bio-Path Holdings's current Scaled Net Operating Assets is -11.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Path Holdings stock overvalued right now?
Bio-Path Holdings (BPTH) has a current Scaled Net Operating Assets of -11.58. The current Scaled Net Operating Assets is -11.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Bio-Path Holdings (BPTH), the current Scaled Net Operating Assets is -11.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Path Holdings Business Description

Address No. 2407, 625 Stanwix Street, Pittsburgh, PA, USA, 15222
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.